Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ANFNYSE:CHWYNYSE:DOC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANFAbercrombie & Fitch$70.30-15.7%$96.74$68.47▼$196.99$3.54B1.451.91 million shs4.57 million shsCHWYChewy$33.61-1.2%$35.68$14.69▼$40.09$13.84B1.687.53 million shs8.01 million shsDOCHealthpeak Properties$19.45-3.1%$20.18$17.80▼$23.26$13.60B1.144.85 million shs4.95 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANFAbercrombie & Fitch+5.75%+9.65%-13.92%-45.71%-36.68%CHWYChewy+1.44%+2.15%-5.18%+0.44%+115.73%DOCHealthpeak Properties+0.27%-1.21%-1.62%-0.45%+9.97%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANFAbercrombie & Fitch4.4992 of 5 stars4.44.01.70.53.30.01.9CHWYChewy3.6742 of 5 stars3.44.00.00.03.22.51.9DOCHealthpeak Properties3.9484 of 5 stars2.43.02.53.73.11.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANFAbercrombie & Fitch 2.75Moderate Buy$140.88100.41% UpsideCHWYChewy 2.74Moderate Buy$38.6815.11% UpsideDOCHealthpeak Properties 2.85Moderate Buy$23.8322.57% UpsideCurrent Analyst Ratings BreakdownLatest ANF, CHWY, and DOC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025CHWYChewyMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$42.00 ➝ $43.003/27/2025CHWYChewyCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$40.00 ➝ $42.003/27/2025CHWYChewyRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$42.00 ➝ $42.003/27/2025CHWYChewyThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$40.00 ➝ $45.003/27/2025CHWYChewyWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$39.00 ➝ $39.003/27/2025CHWYChewyJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $40.003/27/2025CHWYChewyBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$40.00 ➝ $44.003/27/2025CHWYChewyNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold3/24/2025CHWYChewySeaport Res PtnSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold3/17/2025CHWYChewyWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$39.00 ➝ $39.003/6/2025ANFAbercrombie & FitchRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$110.00(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANFAbercrombie & Fitch$4.95B0.72$6.58 per share10.68$20.83 per share3.37CHWYChewy$11.86B1.15$0.33 per share101.32$1.18 per share28.48DOCHealthpeak Properties$543.46M25.03$1.70 per share11.43$12.94 per share1.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANFAbercrombie & Fitch$328.12M$10.716.956.28N/A11.16%46.50%17.53%5/27/2025 (Estimated)CHWYChewy$39.58M$0.8936.9374.682.213.51%24.47%3.66%5/27/2025 (Estimated)DOCHealthpeak Properties$243.14M$0.3555.569.972.179.00%2.61%1.21%4/24/2025 (Estimated)Latest ANF, CHWY, and DOC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2025N/ADOCHealthpeak Properties$0.46N/AN/AN/A$690.76 millionN/A3/26/2025Q4 2025CHWYChewy$0.03$0.28+$0.25$0.05$3.20 billion$3.25 billion3/5/2025Q4 2025ANFAbercrombie & Fitch$3.48$3.57+$0.09$3.57$1.57 billion$1.58 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANFAbercrombie & Fitch$0.801.14%N/A7.47%N/ACHWYChewyN/AN/AN/AN/AN/ADOCHealthpeak Properties$1.226.27%+34.01%348.57%N/ALatest ANF, CHWY, and DOC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/3/2025DOCHealthpeak Propertiesquarterly$0.30505.98%2/14/20252/14/20252/26/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANFAbercrombie & FitchN/A1.400.81CHWYChewyN/A0.740.35DOCHealthpeak Properties0.961.351.35Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANFAbercrombie & FitchN/ACHWYChewy93.09%DOCHealthpeak Properties93.57%Insider OwnershipCompanyInsider OwnershipANFAbercrombie & Fitch2.58%CHWYChewy2.10%DOCHealthpeak Properties0.23%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANFAbercrombie & Fitch31,70050.37 million49.07 millionOptionableCHWYChewy21,300407.19 million398.64 millionOptionableDOCHealthpeak Properties200699.57 million697.47 millionOptionableANF, CHWY, and DOC HeadlinesRecent News About These CompaniesHealthpeak Properties Announces First Quarter 2025 Earnings Release Date and Conference Call DetailsApril 3 at 5:32 PM | gurufocus.comHealthpeak Properties Announces First Quarter 2025 Earnings Release Date and Conference Call DetailsApril 3 at 4:15 PM | businesswire.comGroupama Asset Managment Sells 12,496 Shares of Healthpeak Properties, Inc. (NYSE:DOC)April 3 at 6:17 AM | marketbeat.comThrivent Financial for Lutherans Sells 32,815 Shares of Healthpeak Properties, Inc. (NYSE:DOC)April 3 at 3:25 AM | marketbeat.comHealthpeak Properties, Inc. (NYSE:DOC) Stake Raised by AIA Group LtdApril 2 at 5:24 AM | marketbeat.comSchroder Investment Management Group Sells 747,015 Shares of Healthpeak Properties, Inc. (NYSE:DOC)April 2 at 4:49 AM | marketbeat.comPictet Asset Management Holding SA Buys 57,432 Shares of Healthpeak Properties, Inc. (NYSE:DOC)April 2 at 4:31 AM | marketbeat.comNorges Bank Takes Position in Healthpeak Properties, Inc. (NYSE:DOC)April 2 at 4:22 AM | marketbeat.comKorea Investment CORP Sells 90,500 Shares of Healthpeak Properties, Inc. (NYSE:DOC)April 2 at 4:06 AM | marketbeat.comJim Cramer Thinks Healthpeak Properties, Inc. (DOC) Is a Reasonable Medical REIT – Not in Love with It!April 1 at 7:53 PM | finance.yahoo.comMitsubishi UFJ Trust & Banking Corp Sells 197,478 Shares of Healthpeak Properties, Inc. (NYSE:DOC)April 1 at 3:56 AM | marketbeat.comAnalysts Set Healthpeak Properties, Inc. (NYSE:DOC) Target Price at $23.92April 1 at 1:57 AM | americanbankingnews.comJim Cramer Thinks Healthpeak Properties, Inc. (DOC) Is a Reasonable Medical REIT – Not in Love with It!March 31 at 12:22 PM | insidermonkey.comOrion Portfolio Solutions LLC Trims Stake in Healthpeak Properties, Inc. (NYSE:DOC)March 31 at 4:54 AM | marketbeat.comNomura Asset Management Co. Ltd. Acquires 33,949 Shares of Healthpeak Properties, Inc. (NYSE:DOC)March 31 at 4:46 AM | marketbeat.comNew Age Alpha Advisors LLC Invests $2.41 Million in Healthpeak Properties, Inc. (NYSE:DOC)March 31 at 4:45 AM | marketbeat.comJPMorgan Chase & Co. Reduces Position in Healthpeak Properties, Inc. (NYSE:DOC)March 31 at 4:28 AM | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Grows Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)March 31 at 4:20 AM | marketbeat.comAllstate Corp Trims Holdings in Healthpeak Properties, Inc. (NYSE:DOC)March 30, 2025 | marketbeat.comHealthpeak Properties, Inc. (NYSE:DOC) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMarch 30, 2025 | marketbeat.comDuff & Phelps Investment Management Co. Trims Stake in Healthpeak Properties, Inc. (NYSE:DOC)March 29, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military SpendingBuy the Chewy Stock Reversal? Here’s Why Now Is the TimeBy Thomas Hughes | March 28, 2025View Buy the Chewy Stock Reversal? Here’s Why Now Is the TimeANF, CHWY, and DOC Company DescriptionsAbercrombie & Fitch NYSE:ANF$70.30 -13.10 (-15.70%) Closing price 03:59 PM EasternExtended Trading$69.86 -0.44 (-0.62%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Abercrombie & Fitch Co. engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa. The APAC segment includes operations in the Asia-Pacific region, including Asia and Oceania. The company was founded by David Abercrombie in 1892 and is headquartered in New Albany, OH.Chewy NYSE:CHWY$33.61 -0.39 (-1.16%) Closing price 03:58 PM EasternExtended Trading$33.67 +0.07 (+0.20%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chewy, Inc., together with its subsidiaries, engages in the pure play e-commerce business in the United States. It provides pet food and treats, pet supplies and pet medications, and other pet-health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its retail websites and mobile applications. The company was founded in 2010 and is based in Plantation, Florida.Healthpeak Properties NYSE:DOC$19.44 -0.62 (-3.07%) Closing price 03:59 PM EasternExtended Trading$19.72 +0.27 (+1.39%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom’s VMware Strategy Could Fuel the Next AVGO Rally Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy? Celsius Heats Up: Acquisition, Analyst Upgrade Fuel Momentum 5 Reasons Why Halliburton Is a Good Buy in 2025 First Watch Restaurant Group: A First-Rate Small-Cap Growth Stock Tesla Stock: What To Expect With Their Delivery Numbers Report Rocket Lab: $5.6 Billion Defense Contract Fuels RKLB’s Future Equinix: A Smart Bet on Data Centers, Dividends, and AI Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
